Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by Mn Services Vermogensbeheer B.V.

Mn Services Vermogensbeheer B.V. lessened its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 7.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 26,400 shares of the biotechnology company's stock after selling 2,000 shares during the quarter. Mn Services Vermogensbeheer B.V.'s holdings in Axon Enterprise were worth $13,885,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in AXON. Brighton Jones LLC purchased a new stake in Axon Enterprise during the fourth quarter valued at approximately $480,000. Kingsview Wealth Management LLC purchased a new stake in shares of Axon Enterprise during the 4th quarter valued at $212,000. Empowered Funds LLC boosted its position in shares of Axon Enterprise by 89.2% in the 4th quarter. Empowered Funds LLC now owns 1,871 shares of the biotechnology company's stock worth $1,112,000 after purchasing an additional 882 shares in the last quarter. Savant Capital LLC grew its stake in Axon Enterprise by 5.7% during the 4th quarter. Savant Capital LLC now owns 1,080 shares of the biotechnology company's stock worth $642,000 after buying an additional 58 shares during the last quarter. Finally, Avestar Capital LLC purchased a new position in Axon Enterprise during the 4th quarter worth $220,000. 79.08% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, CFO Brittany Bagley sold 3,400 shares of the company's stock in a transaction dated Tuesday, May 13th. The shares were sold at an average price of $700.00, for a total transaction of $2,380,000.00. Following the completion of the transaction, the chief financial officer now owns 131,833 shares in the company, valued at $92,283,100. This represents a 2.51% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Patrick W. Smith sold 10,000 shares of the business's stock in a transaction that occurred on Monday, April 21st. The stock was sold at an average price of $540.99, for a total value of $5,409,900.00. Following the sale, the chief executive officer now owns 3,063,982 shares of the company's stock, valued at approximately $1,657,583,622.18. This trade represents a 0.33% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 43,662 shares of company stock valued at $29,739,909. 4.40% of the stock is owned by corporate insiders.

Axon Enterprise Stock Performance

Shares of NASDAQ AXON traded down $0.02 during midday trading on Monday, reaching $780.61. 470,479 shares of the stock were exchanged, compared to its average volume of 717,558. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The firm has a market cap of $60.77 billion, a price-to-earnings ratio of 201.71, a PEG ratio of 5.17 and a beta of 1.29. The firm has a 50-day simple moving average of $669.47 and a two-hundred day simple moving average of $621.44. Axon Enterprise, Inc. has a twelve month low of $279.02 and a twelve month high of $806.64.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last posted its earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.34 by $0.07. The business had revenue of $603.63 million for the quarter, compared to analyst estimates of $585.67 million. Axon Enterprise had a net margin of 15.37% and a return on equity of 7.50%. The company's revenue for the quarter was up 31.3% on a year-over-year basis. During the same period in the prior year, the company posted $1.15 EPS. As a group, analysts anticipate that Axon Enterprise, Inc. will post 5.8 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on the company. Bank of America raised their price target on Axon Enterprise from $750.00 to $895.00 and gave the stock a "buy" rating in a report on Wednesday, June 4th. Barclays upped their price target on shares of Axon Enterprise from $726.00 to $735.00 and gave the company an "overweight" rating in a research note on Friday, May 9th. Northcoast Research downgraded shares of Axon Enterprise from a "buy" rating to a "neutral" rating in a research note on Wednesday, February 19th. Needham & Company LLC upped their target price on Axon Enterprise from $600.00 to $750.00 and gave the company a "buy" rating in a research report on Thursday, May 8th. Finally, The Goldman Sachs Group lifted their price target on Axon Enterprise from $730.00 to $830.00 and gave the stock a "buy" rating in a research report on Wednesday, May 14th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and ten have assigned a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $699.55.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.